Insufficient Evidence for Collagen Supplementation: A Critical Examination of Skin, Musculoskeletal, and Joint Health Claims

Abstract

Background: Collagen supplementation has grown exponentially in the nutraceutical market, driven by marketing claims of benefits for skin aging, body composition, and joint health. This narrative review critically examines current evidence for oral collagen supplementation across these domains, emphasizing methodological quality, industryfunding influence, and biological plausibility. Methods: A literature search of PubMed and Google Scholar identified randomized controlled trials, systematic reviews, meta-analyses, and commentaries published between 2000 and June 2025, with an updated search in December 2025 to capture subsequently published trials, meta-analyses, and published corrections. Data were synthesized thematically to evaluate the strength of evidence and identify conflicts between marketing claims and scientific findings. Screening and selection followed a structured narrative-review approach; risk of bias and certainty of evidence were taken from the appraisals reported within the included reviews rather than from de novo assessment of individual trials. Where recent syntheses reached differing conclusions, the individual trials underlying their pooled estimates were retrieved and appraised against the primary reports. Results: For skin health, apparent benefits from pooled analyses disappeared entirely when studies were stratified by funding source and methodological quality. Studies without pharmaceutical company funding showed no significant effects on skin hydration, elasticity, or wrinkles, while industry-funded studies demonstrated significant improvements. Statistical heterogeneity was extremely high across multiple meta-analyses, with I2. values of 78–98%. For musculoskeletal outcomes, systematic reviews found inconsistent results, with evidence suggesting that total protein quantity and amino acid profile may be more influential than protein type for muscle protein synthesis and body composition. Critical examination of remarkable body composition claims identified significant mechanistic implausibility regarding leucine content and proposed anabolic pathways. For joint health, recent meta-analyses report small improvements in osteoarthritis pain and function. The largest and most methodologically current of these produced a pooled pain effect (SMD −0.35) that falls below the minimal clinically important difference its own authors pre-specified (−0.37), concentrated that effect in undenatured type II collagen rather than in the hydrolysate preparations that dominate the consumer market, showed statistically significant small-study bias until the smallest trials were excluded, and classified as independently funded no trial that tested oral collagen against placebo in knee osteoarthritis. Studies in healthy individuals with knee pain and patients with knee osteoarthritis showed no benefit over placebo. Conclusions: Current evidence does not support collagen supplementation for skin health, body composition, or muscle strength when analyses are restricted to high-quality, independently funded research. For joint health, a small pooled benefit is reported, but it falls below the threshold for clinical importance nominated by the syntheses reporting it and rests on a literature in which oral supplementation has not been tested against placebo by independently funded investigators. The evidence base is characterized by methodological heterogeneity, potential industry-funding influence, and signs of publication bias. Until large, well-designed trials demonstrate clinically meaningful benefits compared with non-collagen protein sources, with plausible biological mechanisms, collagen supplementation should not be recommended as an evidence-based intervention.